An early-phase trial found that a personalized vaccine targeted and destroyed cancer cells in nine patients with advanced kidney cancer, effectively wiping out the disease and keeping it at bay ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...
Pope Francis, who has been hospitalized for more than a week, had a peaceful night which “passed quietly” after suffering ...
Tennessee Attorney General Jonathan Skrmetti is leading a bipartisan coalition urging the Food and Drug Administration to ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
Alembic is introducing diltiazem hydrochloride extended-release capsules 120 mg, 180 mg and 240 mg, which are the generic of ...
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results